Axonal damage revealed by accumulation of β-amyloid precursor protein in HTLV-I-associated myelopathy

Journal of the Neurological Sciences

Volumn 176, Issue 2, 2000, Pages 95-101

  Umehara, Fujio ^a   Abe, Mayumi ^a   Koreeda, Yoshifusa ^a   Izumo, Shuji ^b   Osame, Mitsuhiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Kagoshima University   (Japan)

Author keywords

amyloid precursor protein; Axonal damage; Axonal flow; HAM TSP; HTLV I; HTLV I associated myelopathy

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOREACTIVITY; MALE; PARAPLEGIA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPINAL CORD DISEASE; WHITE MATTER;

AGED; AMYLOID BETA-PROTEIN PRECURSOR; AXONAL TRANSPORT; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE DEGENERATION; PARAPARESIS, TROPICAL SPASTIC; SPINAL CORD;

EID: 0034659179     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00324-5     Document Type: Article

References (35)

1. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., de-The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 2:1985;407-410.
2. Osame M., Matsumoto M., Usuku K., Izumo S., Ijichi N., Amitani H., Tara M., Igata A. Chronic progressive myelopathy associated with elevated antibodies to human lymphotropic virus type-I and adult T cell leukemia-like cells. Ann Neurol. 21:1987;117-122.
3. Umehara F., Izumo S., Nakagawa M., Ronquillo A.T., Takahashi K., Sato E., Osame M. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 53:1993;424-430.
4. Umehara F., Izumo S., Ronquillo A.T., Matsumuro K., Sato E., Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 53:1994;72-77.
5. Umehara F., Nakamura A., Izumo S., Kubota R., Ijichi S., Kashio N., Hashimoto K., Usuku K., Sato E., Osame M. Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to control viral infection in the central nervous system. J Neuropathol Exp Neurol. 53:1994;617-624.
6. Umehara F., Izumo S., Takeya M., Sato E., Osame M. Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol. 91:1996;343-350.
7. Umehara F., Okada Y., Fujimoto N., Abe M., Izumo S., Osame M. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 57:1998;839-849.
8. Iwasaki Y. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci. 96:1990;103-123.
9. Moore G.R.W., Traugott U., Scheinberg L.C., Raine C.S. Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell mediated demyelination? Ann Neurol. 26:1989;523-530.
10. Erb D.E., Povliishock J.T. Axonal damage in severe traumatic brain injury: an experimental study in cat. Acta Neuropathol. 76:1988;347-358.
11. Gentleman S.M., Nash M.J., Sweeting C.J., Graham D.I., Roberts G.W. β-amyloid precursor protein (β-APP) as a marker for axonal injury after head injury. Neurosci Lett. 160:1993;139-144.
12. McKenzie K.J., McLellan D.R., Gentleman S.M., Maxwell W.L., Gennarelli T.A., Gnaham D.I. Is β-APP a marker of axonal damage in short-surviving head injury? Acta Neuropathol. 92:1996;608-613.
13. Povlishock J.J., Becker D.P., Cheng C.L.Y., Vaughan G.W. Axonal change in minor head injury. J Neuropathol Exp Neurol. 42:1983;225-242.
14. Povlinshock J.T. Traumatically induced axonal injury: pathogenesis and pathological implications. Brain Pathol. 2:1992;1-12. Review.
15. Sherriff F.E., Bridges L.R., Gentleman S.M., Sivalogannathan S., Wilson S. Marks of axonal injury in post mortem human brain. Acta Neuropathol. 88:1994;433-439.
16. Sherriff F.E., Bridges L.R., Sivaloganathan S. Early detection of axonal injury after human head trauma using immunocytochemistry for β-amyloid precursor protein. Acta Neuropathol. 87:1997;55-62.
17. Ferguson B., Matyszak M.K., Esiri M.M., Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain. 120:1997;393-399.
18. Gehrmann J., Banati R.B., Cuzner M.L., et al. Amyloid precursor protein (APP) expression in multiple sclerosis lesions. Glia. 15:1995;141-151.
19. An S.F., Giometto B., Groves M., Miller R.F., Beckett A.A.J., Gray F., Tavolato B., Scarravilli F. Axonal damage revealed by accumulation of β-amyloid precursor protein in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol. 56:1997;1262-1268.
20. Giometto B., An S.F., Groves M., Scaaravilli T., Geddes J.F., Miller R., Tavolato B., Beckett A.A.J., Scaaravilli F. Accumulation of β-amyloid precursor protein in HIV encephalitis: relationship with neurophysiological abnormalities. Ann Neurol. 42:1997;34-40.
21. Cochran E., Bacci B., Chen Y., Patton A., Gambetti P., Antilio-Gambetti L. Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease. Am J Pathol. 139:1991;485-489.
22. Ohgami T., Kitamoto T., Tateishi J. Alzheimer's amyloid precursor protein accumulate within axonal swellings in human brain lesions. Neurosci Lett. 136:1992;75-78.
23. Koo E.H., Sisodia S.S., Archer D.R., Martin L.J., Weidemann A., Beyreuther K., Fisher P., Masters C.L., Price D.L. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA. 87:1990;1561-1565.
24. Griffin J.W., Price D.L., Engel W.K., Drachman D.B. The pathogenesis of active axonal swellings: role of axonal transport. J Neuropathol Exp Neurol. 36:1987;214-227.
25. Abe M., Umehara F., Kubota R., Moritoyo T., Izumo S., Osame M. Activation of macrophage/microglias with expression of MRP8 and MRP14 is associated with the lesional activities in the spinal cord lesions in HTLV-I associated myelopathy. J Neurol. 246:1999;358-364.
26. Sasaki S., Iwata M. Immunoreactivity of β-amyloid precursor protein in amyotrophic lateral sclerosis. Acta Neuropathol. 97:1999;463-468.
27. Umehara F., Izumo S., Zyounosono M., Osame M. An autopsied case of the Crow-Fukase syndrome: a neuropathological study with emphasis on spinal roots. Acta Neuropathol. 80:1990;563-567.
28. Moritoyo T., Reinhart T.A., Moritoyo H., Sato E., Izumo S., Osame M., Haase A.T. Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol. 40:1996;84-90.
29. Brennenman D.E., Westbrook G.L., Fitzgerald S.P., Ennist D.L., Elkins K.L., Ruff M.R., Rert C.B. Neuronal cell killing by the envelope protein of HIV and its prevention by basoactive intestinal peptide. Nature. 335:1988;639-642.
30. Arimura K., Arimura Y., Moritoyo H., Tokimura Y., Takenaga S., Sonoda Y., Yamanaka H., Nakagawa M., Izumo S., Osame M. How helpful is thoracic paraspinal EMG in HAM/TSP? Muscle Nerve. 18:1995;248-250.
31. Refolo L.M., Wittenberg I.S., Freidrich V.L. Jr., Robakis N.K. The Alzheimer amyloid precursor is associated with the detergent-insoluble cytoskeleton. J Neurosci. 11:1991;3888-3897.
32. Amaratunga A., Leeman S.E., Kosik K.S., Fine R.E. Inhibition of kinesin synthesis in vivo inhibits the rapid transport of representative proteins for three transport vesicles into the axon. J Neurochem. 64:1995;2374-2376.
33. Izumo S., Goto I., Itoyama Y., Okajima T., Watanabe S., Kuroda Y., Araki S., Mori M., Nagataki S., Matsukura S., Akamine T., Nakagawa M., Yamamoto I., Osame M. Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology. 46:1996;1016-1021.
34. Kataoka A., Imai H., Inayoshi S., Tsuda T. Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy. J Neurol Neurosurg Psychiatry. 56:1993;1213-1216.
35. Tsujino A., Nakamura T., Nishiura Y., Shirabe S., Furuya T., Goto H., Kawakami A., Eguchi K., Nagataki S. Pentoxifylline down-regulates adhesion molecule expression and inflammatory cytokine production in cultured peripheral blood mononuclear cells from patients with HTLV-I-associated myelopathy. J Neuroimmunol. 73:1997;191-196.